Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04796259 Completed - Clinical trials for Acute Response to Food Ingredient Consumption

Malt-derived Ingredients and Their Prolactinotrophic Effects

Start date: February 5, 2021
Phase: N/A
Study type: Interventional

This proof-of-concept study aims to investigate whether malt-derived ingredients have acute prolactinotrophic effects in healthy women of child-bearing age.

NCT ID: NCT04796207 Completed - Clinical trials for Traumatic Brain Injury (TBI)

The Effects of Fish Oil Supplementation on the Brain Health of Collegiate Football Athletes

Start date: May 28, 2019
Phase: N/A
Study type: Interventional

Determine if the daily docosahexaenoic acid (DHA)/eicosapentaenoic acid (EPA) supplement will reduce serum levels of biomarkers of sub-concussion injuries over a course of American football season among collegiate football athletes.

NCT ID: NCT04796077 Completed - Clinical trials for Pediatric Preoperative Anxiety, Pediatric Coping

Preparing Children for Anesthesia With an Educational Pop-Up Book

Start date: August 26, 2020
Phase: N/A
Study type: Interventional

The study evaluated an educational pop-up book about general anesthesia induction as an interactive, child-focused preoperative education resource for pediatric patients undergoing outpatient surgery. The study's objectives were to evaluate the book as an educational tool and to understand the book's effects on patient and caregiver perceptions of the surgical experience. The study's hypotheses were that preoperative education from the pop-up book, compared to standard care, would more effectively reduce children's fear and expected pain, facilitate more positive views of the procedure and preoperative explanations, encourage adaptive coping strategies, reduce behavioral anxiety at anesthesia induction, and increase caregiver satisfaction with the surgical experience.

NCT ID: NCT04795622 Completed - Clinical trials for Improvement in Skin Laxity of the Lower Face and Submentum

Evaluation of the Effectiveness and Safety of the Ulthera® DeepSEE® System for Treating Skin Laxity in the Lower Face and Submentum

Start date: March 16, 2021
Phase: N/A
Study type: Interventional

1. Demonstrate superiority of treatment with the Ulthera DeepSEE System compared to untreated control for the improvement of skin laxity of the lower face and submental area. 2. Demonstrate the safety of treatment with the Ulthera DeepSEE System for the improvement of skin laxity of the lower face and submental area.

NCT ID: NCT04795323 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Proof of Concept Study Assessing Technology-Assisted Respiratory Adherence Prototype Version 3 in Individuals With COPD

Start date: April 8, 2021
Phase: Phase 2
Study type: Interventional

The study's primary aim is to assess whether there is a clinically significant reduction in breathlessness in symptomatic individuals with chronic obstructive respiratory disease (IwCOPD) following engagement with Technology-Assisted Respiratory Adherence prototype 3. The study's secondary aim is to assess whether there is an associated maintenance or increase in activities of daily living to support a positive benefit of Technology-Assisted Respiratory Adherence prototype 3 on breathlessness and whether there is an improvement in the physical activity experience of the patient.

NCT ID: NCT04795245 Completed - Clinical trials for Non-squamous, Non-Small Cell Lung Cancer

Non-interventional Study for Real-world Data of Afatinib Treatment in First-line Setting and of Subsequent Therapies for Patients With Advanced Epidermal Growth Factor Receptor (EGFR) Mutation-positive Lung Adenocarcinoma

Start date: August 26, 2021
Phase:
Study type: Observational

The primary objective is to confirm Time on Treatment (TOT) related to afatinib treatment as first-line therapy in patients with Epidermal Growth Factor Receptor (EGFR) mutation-positive Non-Small Cell Lung Cancer (NSCLC). The observation in the real-world setting of the time from the start of the first-line afatinib until the end of subsequent treatment in this study will provide insights on the sequence of treatment for patients. The Japanese healthcare system will enable this study to evaluate multiple treatment options after afatinib treatment.

NCT ID: NCT04794764 Completed - Clinical trials for Pulmonary Aspiration of Gastric Contents

Videolaryngoscopy Compared to Direct Laryngoscopy

LARA
Start date: July 24, 2021
Phase: N/A
Study type: Interventional

Videolaryngoscope (Macintosh-type blade) compared with direct laryngoscopy for rapid sequence intubation in the operating room

NCT ID: NCT04794634 Completed - Alzheimer Disease Clinical Trials

Relationship Between Alzheimer Disease and Diminution of the Three Macular Nervous Retinal Layers

RETEVAL
Start date: March 9, 2021
Phase: N/A
Study type: Interventional

Alzheimer disease is hard, long and expensive to diagnose. In order to help the clinician, a new biomarker in Alzheimer disease seems to be very useful. The retina, as a window of the brain, could offer a new way to diagnose this common disease. Indeed, a retinal atrophy could especially appear in Alzheimer disease. Besides, many aspects about retinal alteration, visual function and their link with the disease deserve to be more explored. So as to fill these gaps, a new study about retinal specificity in Alzheimer disease appears to be relevant.

NCT ID: NCT04794153 Completed - Clinical trials for Nutritional Intervention Using Protein Rich Whole Food Sources

Investigating the Consumption of Different Protein Rich Whole Food Sources on Muscle Growth in Trained Males and Females

FFT
Start date: May 1, 2021
Phase: N/A
Study type: Interventional

Background To date, most of the literature investigating the role of dietary protein in muscle growth has focused on isolated protein sources. However, dietary protein is most commonly consumed within a whole food source. Consuming dietary protein within a whole food matrix may additionally stimulate muscle growth. The idea being, there may be other components within food, capable of producing a greater response. Objectives: To assess the effect of consuming a variety of whole food sources, on the stimulation of muscle growth compared to an isolated protein source following a single bout of lower body resistance exercise. Methods Young healthy resistance-trained volunteers will consume a protein rich whole food source, following a bout of lower body resistance exercise. Stable isotope IV infusions and repeated blood and muscle samples will be taken to assess protein digestion and absorption, as well as muscle protein synthesis rates. Value of Research: To determine whether whole food sources potentiate muscle protein synthesis rates (and to what extent across whole food sources) compared to an isolated protein source. In doing so, we can further investigate the nutrients involved that may be contributing to this effect.

NCT ID: NCT04793815 Completed - Clinical trials for Non-small Cell Lung Cancer Metastatic

Lung Cancer Cryo-Activation as a Novel Approach to Augment Immunotherapy Efficacy (CRYOVATE)

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

Cryo-activation involves the insertion of a cryoprobe in the tumor bed with subsequent cell necrosis and tumor antigens release. Such technique has the potential to induce immune-specific reactions influencing cancer cells outside of the ablated region. The addition of cryo-activation to immune-checkpoint blockers (ICB) in the advanced NSCLC setting could represent a synergistic therapeutic avenue in order to potentiate treatment responses